Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572110
Project Independence: Randomized Controlled TrialUniversity of MiamiNot Yet RecruitingNot Applicable
NCT07572110Not Yet Recruiting
Not Applicable
Project Independence: Randomized Controlled TrialUniversity of Miami
NCT07574346
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People's HospitalNot Yet RecruitingEarly Phase 1
NCT07574346Not Yet Recruiting
Early Phase 1
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People'...
NCT07572604
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Not Yet RecruitingNot Applicable
NCT07572604Not Yet Recruiting
Not Applicable
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver Na...
NCT07573202
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to Evaluate Hypersensitivity Reactions in Shoulder SurgeryThe University of Texas Health Science Center, HoustonNot Yet RecruitingNot Applicable
NCT07573202Not Yet Recruiting
Not Applicable
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to...The University of Texas H...
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07573514
Patients With Primary Biliary CholangitisFondazione Policlinico Universitario Agostino Gemelli IRCCSActive Not RecruitingNot Applicable
NCT07573514Active Not Recruiting
Not Applicable
Patients With Primary Biliary CholangitisFondazione Policlinico Un...
NCT07572045
Promoting Interventions for Climate Change to Upscale Resilience in District BadinDr Jai Kumar DasNot Yet RecruitingNot Applicable
NCT07572045Not Yet Recruiting
Not Applicable
Promoting Interventions for Climate Change to Upscale Resilience in District Bad...Dr Jai Kumar Das
NCT07574372
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou General HospitalCompletedNot Applicable
NCT07574372Completed
Not Applicable
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou Genera...
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07574255
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical ApplicationNational Taiwan University HospitalNot Yet Recruiting
NCT07574255Not Yet Recruiting
—
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical ApplicationNational Taiwan Universit...
NCT07572656
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe PreeclampsiaMuhammad Aamir LatifCompletedNot Applicable
NCT07572656Completed
Not Applicable
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preecl...Muhammad Aamir Latif
NCT07573839
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Using Sentiment Analysis Technology Based on Multi-modal Feature FusionShanghai Mental Health CenterRecruiting
NCT07573839Recruiting
—
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Us...Shanghai Mental Health Ce...
NCT07573501
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates Working Memory of Patients With Post-stroke Cognitive ImpairmentKe Dong, MDNot Yet RecruitingNot Applicable
NCT07573501Not Yet Recruiting
Not Applicable
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates...Ke Dong, MD
NCT07572669
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRecruitingPhase 2
NCT07572669Recruiting
Phase 2
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogen...Union Hospital, Tongji Me...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572305
Effects of Virtual Reality After Liver TransplantationMalatya Turgut Ozal UniversityCompletedNot Applicable
NCT07572305Completed
Not Applicable
Effects of Virtual Reality After Liver TransplantationMalatya Turgut Ozal Unive...
NCT07572292
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine PositionVrije Universiteit BrusselNot Yet RecruitingNot Applicable
NCT07572292Not Yet Recruiting
Not Applicable
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine Po...Vrije Universiteit Brusse...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07572513
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue UniversityRecruitingNot Applicable
NCT07572513Recruiting
Not Applicable
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue University
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable12 (60%)
Not Specified3 (15%)
Phase 22 (10%)
Phase 12 (10%)
Early Phase 11 (5%)